| Filed On | Filing |
|---|---|
| 02 Apr 2024 |
8-K/A: Other Events
Phoenix Biotech Acquisition Corp. (“PBAX” and, after the Business Combination (as defined below), “New CERo”) is providing the following unaudited pro forma condensed combined financial information to aid you in your analysis of the fina... |
| 27 Feb 2024 |
8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 14, 2024, is by and among Phoenix Biotech Acquisition Corp., a Delaware corporation with offices located at 2201 Broadway, Suite 705, Oakland, CA 94612 (the “Comp... |
| 18 Jul 2023 |
8-K/A: Other Events
In connection with the approval of the Charter Amendment, holders of 523,341 shares of the Company’s Class A common stock, par value $0.0001 per share (“Class A Shares”), exercised redemption rights. As a result, following satisfaction o... |
Loading...